Total Payments
$4,441
2024 Payments
$1,288
Companies
41
Transactions
245
Medicare Patients
400
Medicare Billing
$37,302
Payment Breakdown by Category
Food & Beverage$3,941 (88.7%)
Research$500.00 (11.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,941 | 244 | 88.7% |
| Unspecified | $500.00 | 1 | 11.3% |
Payments by Type
General
$3,941
244 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lucid Diagnostics Inc. | $558.15 | 5 | $0 (2023) |
| ABBVIE INC. | $531.27 | 35 | $0 (2024) |
| Lilly USA, LLC | $465.18 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $361.13 | 15 | $0 (2024) |
| Novo Nordisk Inc | $340.36 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $284.31 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $251.65 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $149.99 | 7 | $0 (2024) |
| Amgen Inc. | $143.69 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $122.80 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,288 | 68 | AstraZeneca Pharmaceuticals LP ($238.17) |
| 2023 | $1,719 | 83 | Lucid Diagnostics Inc. ($509.61) |
| 2022 | $1,226 | 81 | Lilly USA, LLC ($149.89) |
| 2021 | $166.98 | 11 | AstraZeneca Pharmaceuticals LP ($39.21) |
| 2018 | $40.76 | 2 | AstraZeneca Pharmaceuticals LP ($26.51) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Cranial Orthotic | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Bone Health | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Biological | ||||||
| 09/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Biological | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | Lucid Diagnostics Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 211 | 287 | $40,935 | $20,248 |
| 2022 | 5 | 153 | 197 | $30,470 | $14,457 |
| 2021 | 3 | 36 | 42 | $4,780 | $2,597 |
Total Patients
400
Total Services
526
Medicare Billing
$37,302
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 121 | $21,175 | $9,631 | 45.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $8,580 | $4,780 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 42 | $6,090 | $2,665 | 43.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $2,600 | $1,895 | 72.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,040 | $733.25 | 70.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 16 | 16 | $1,280 | $486.13 | 38.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 17 | $170.00 | $57.97 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 76 | $13,300 | $5,757 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $7,700 | $4,365 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 46 | $6,670 | $2,372 | 35.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 20 | 20 | $2,000 | $1,405 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $800.00 | $557.20 | 69.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 17 | $2,975 | $1,581 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $1,625 | $835.48 | 51.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 12 | 12 | $180.00 | $180.00 | 100.0% |
About Dr. Antonina Callahan, MD
Dr. Antonina Callahan, MD is a Family Medicine healthcare provider based in Bountiful, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2018. The National Provider Identifier (NPI) number assigned to this provider is 1699260620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Antonina Callahan, MD has received a total of $4,441 in payments from pharmaceutical and medical device companies, with $1,288 received in 2024. These payments were reported across 245 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,941).
As a Medicare-enrolled provider, Callahan has provided services to 400 Medicare beneficiaries, totaling 526 services with total Medicare billing of $37,302. Data is available for 3 years (2021–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bountiful, UT
- Active Since 06/22/2018
- Last Updated 12/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699260620
Products in Payments
- VRAYLAR (Drug) $363.11
- TRADJENTA (Drug) $206.01
- MOUNJARO (Drug) $192.60
- FARXIGA (Drug) $188.91
- SHINGRIX (Biological) $165.10
- Veozah (Drug) $149.99
- NURTEC ODT (Drug) $137.88
- SPRAVATO (Drug) $122.80
- TRELEGY ELLIPTA (Drug) $119.21
- Kerendia (Drug) $115.07
- EMGALITY (Drug) $108.77
- Rybelsus (Drug) $101.63
- CAPLYTA (Drug) $91.45
- ENHERTU (Biological) $89.12
- Korlym (Drug) $87.81
- Otezla (Drug) $86.42
- QULIPTA (Drug) $78.80
- Ozempic (Drug) $74.30
- REXULTI (Drug) $72.22
- Doc Band (Device) $69.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bountiful
Scott Erickson
Family Medicine — Payments: $135,999
Family Medicine $135,999
Allen Freestone, Md, MD
Family Medicine — Payments: $9,138
Family Medicine $9,138
David Cope, Md, MD
Family Medicine — Payments: $6,614
Family Medicine $6,614
William Draper, Do, DO
Family Medicine — Payments: $5,187
Family Medicine $5,187
Dr. Brian Rodgers, D. O, D. O
Family Medicine — Payments: $4,368
Family Medicine $4,368
Allison Hanna, D.o, D.O
Family Medicine — Payments: $2,662
Family Medicine $2,662